000 01141 a2200325 4500
005 20250516092654.0
264 0 _c20121226
008 201212s 0 0 eng d
022 _a1873-4286
024 7 _a10.2174/138161212802002797
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDijkgraaf, Eveline M
245 0 0 _aInterleukin-6/interleukin-6 receptor pathway as a new therapy target in epithelial ovarian cancer.
_h[electronic resource]
260 _bCurrent pharmaceutical design
_c2012
300 _a3816-27 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInterleukin-6
_xmetabolism
650 0 4 _aOvarian Neoplasms
_xmetabolism
650 0 4 _aPrognosis
650 0 4 _aReceptors, Interleukin-6
_xmetabolism
700 1 _aWelters, Marij J P
700 1 _aNortier, Johan W R
700 1 _avan der Burg, Sjoerd H
700 1 _aKroep, Judith R
773 0 _tCurrent pharmaceutical design
_gvol. 18
_gno. 25
_gp. 3816-27
856 4 0 _uhttps://doi.org/10.2174/138161212802002797
_zAvailable from publisher's website
999 _c21786482
_d21786482